{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:54:31Z","timestamp":1771476871920,"version":"3.50.1"},"reference-count":72,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sexual Medicine Reviews"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1002\/smrj.54","type":"journal-article","created":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T15:02:08Z","timestamp":1431702128000},"page":"289-297","source":"Crossref","is-referenced-by-count":16,"title":["The History of Collagenase Clostridium Histolyticum"],"prefix":"10.1093","volume":"3","author":[{"given":"Kevin K.","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1002\/smrj.54_bb0010","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0022-5347(01)64222-8","article-title":"Penile trauma: An etiologic factor in Peyronie's disease and erectile dysfunction","volume":"158","author":"Jarow","year":"1997","journal-title":"J Urol"},{"key":"10.1002\/smrj.54_bb0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-5347(01)65367-9","article-title":"Fibrin deposition in Peyronie's disease plaque","volume":"157","author":"Somers","year":"1997","journal-title":"J Urol"},{"key":"10.1002\/smrj.54_bb0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0022-5347(17)40920-7","article-title":"Isolation and characterization of collagen in Peyronie's disease","volume":"141","author":"Somers","year":"1989","journal-title":"J Urol"},{"key":"10.1002\/smrj.54_bb0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/j.1939-4640.1996.tb01757.x","article-title":"Ultrastructural and immunohistochemical characterization of the tunica albuginea in Peyronie's disease and veno-occlusive dysfunction","volume":"17","author":"Gentile","year":"1996","journal-title":"J Androl"},{"key":"10.1002\/smrj.54_bb0030","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0022-5347(01)65360-6","article-title":"The microscopic pathology of Peyronie's disease","volume":"157","author":"Davis","year":"1997","journal-title":"J Urol"},{"issue":"suppl 3","key":"10.1002\/smrj.54_bb0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1743-6109.2008.01195.x","article-title":"Mechanisms of penile fibrosis","volume":"6","author":"Gonzalez-Cadavid","year":"2009","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.54_bb0040","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/j.juro.2008.01.093","article-title":"Differential calcium independent regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by interleukin-1beta and transforming growth factor-beta in Peyronie's plaque fibroblasts","volume":"179","author":"Del Carlo","year":"2008","journal-title":"J Urol"},{"key":"10.1002\/smrj.54_bb0045","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0090-4295(01)01578-3","article-title":"Gene expression profiles in the Peyronie's disease plaque","volume":"59","author":"Magee","year":"2002","journal-title":"Urology"},{"key":"10.1002\/smrj.54_bb0050","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","article-title":"The prevalence of Peyronie's disease: Results of a large survey","volume":"88","author":"Schwarzer","year":"2001","journal-title":"BJU Int"},{"key":"10.1002\/smrj.54_bb0055","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0022-5347(05)01018-9","article-title":"Erectile function profiles in men with Peyronie's disease","volume":"175","author":"Deveci","year":"2006","journal-title":"J Urol"},{"key":"10.1002\/smrj.54_bb0060","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1743-6109.2012.02999.x","article-title":"Psychological impact of Peyronie's disease: A review","volume":"10","author":"Nelson","year":"2013","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.54_bb0065","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","article-title":"An analysis of the natural history of Peyronie's disease","volume":"175","author":"Mulhall","year":"2006","journal-title":"J Urol"},{"key":"10.1002\/smrj.54_bb0070","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/bju.12565","article-title":"Outcomes of surgical treatment of Peyronie's disease","volume":"113","author":"Carson","year":"2014","journal-title":"BJU Int"},{"key":"10.1002\/smrj.54_bb0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1743-6109.2004.10104.x","article-title":"Summary of the recommendations on sexual dysfunctions in men","volume":"1","author":"Lue","year":"2004","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.54_bb0080","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11934-014-0415-4","article-title":"Update on medical management of Peyronie's disease","volume":"15","author":"Tan","year":"2014","journal-title":"Curr Urol Rep"},{"key":"10.1002\/smrj.54_bb0085","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/j.1743-6109.2010.01850.x","article-title":"The management of Peyronie's disease: Evidence-based 2010 guidelines","volume":"7","author":"Ralph","year":"2010","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.54_bb0090","first-page":"32","article-title":"Peyronie's disease; cortisone-hyaluronidase-hydrocortisone therapy","volume":"20","author":"Bodner","year":"1953","journal-title":"Trans West Sect Am Urol Assoc"},{"key":"10.1002\/smrj.54_bb0095","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0022-5347(17)67169-6","article-title":"Peyronie's disease: Results with dermo-jet injection of dexamethasone","volume":"114","author":"Winter","year":"1975","journal-title":"J Urol"},{"key":"10.1002\/smrj.54_bb0100","first-page":"165","article-title":"Betamethasone vs. placebo in Peyronie's disease","volume":"70","author":"Cipollone","year":"1998","journal-title":"Arch Ital Urol Androl"},{"key":"10.1002\/smrj.54_bb0105","first-page":"250","article-title":"Orgotein, a new drug for the treatment of Peyronie's disease","volume":"4","author":"Bartsch","year":"1981","journal-title":"Eur J Rheumatol Inflamm"},{"key":"10.1002\/smrj.54_bb0110","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000473262","article-title":"Peyronie's disease: Experience of local treatment with Orgotein","volume":"7","author":"Gustafson","year":"1981","journal-title":"Eur Urol"},{"key":"10.1002\/smrj.54_bb0115","first-page":"169","article-title":"Orgotein in the treatment of plastic induration of the penis (Peyronie's disease)","volume":"25","author":"Primus","year":"1993","journal-title":"Int Urol Nephrol"},{"key":"10.1002\/smrj.54_bb0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/00365599109024539","article-title":"Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons-alpha, -beta and -gamma","volume":"25","author":"Duncan","year":"1991","journal-title":"Scand J Urol Nephrol"},{"key":"10.1002\/smrj.54_bb0125","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1464-410X.1997.02849.x","article-title":"Intralesional interferon in the treatment of Peyronie's disease: A pilot study","volume":"79","author":"Judge","year":"1997","journal-title":"Br J Urol"},{"key":"10.1002\/smrj.54_bb0130","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.urology.2005.11.005","article-title":"Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: A randomized and prospective study","volume":"67","author":"Inal","year":"2006","journal-title":"Urology"},{"key":"10.1002\/smrj.54_bb0135","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0022-5347(06)00517-9","article-title":"Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease","volume":"176","author":"Hellstrom","year":"2006","journal-title":"J Urol"},{"key":"10.1002\/smrj.54_bb0140","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0022-5347(17)35291-6","article-title":"Intralesional verapamil injection for the treatment of Peyronie's disease","volume":"151","author":"Levine","year":"1994","journal-title":"J Urol"},{"key":"10.1002\/smrj.54_bb0145","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.juro.2012.08.191","article-title":"A comparative study of the efficacy of intralesional verapamil vs. normal saline injection in a novel Peyronie disease animal model: Assessment of immunohistopathological changes and erectile function outcome","volume":"189","author":"Chung","year":"2013","journal-title":"J Urol"},{"key":"10.1002\/smrj.54_bb0150","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1073\/pnas.93.11.5478","article-title":"Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix","volume":"93","author":"Roth","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/smrj.54_bb0155","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0022-5347(01)64224-1","article-title":"Treatment of Peyronie's disease with intralesional verapamil injection","volume":"158","author":"Levine","year":"1997","journal-title":"J Urol"},{"key":"10.1002\/smrj.54_bb0160","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0090-4295(97)00700-0","article-title":"Use of intralesional verapamil to dissolve Peyronie's disease plaque: A long-term single-blind study","volume":"51","author":"Rehman","year":"1998","journal-title":"Urology"},{"key":"10.1002\/smrj.54_bb0165","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0022-5347(05)64691-5","article-title":"Experience with intraplaque injection of verapamil for Peyronie's disease","volume":"168","author":"Levine","year":"2002","journal-title":"J Urol"},{"key":"10.1002\/smrj.54_bb0170","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1046\/j.1464-410X.2002.02738.x","article-title":"Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease","volume":"89","author":"Cavallini","year":"2002","journal-title":"BJU Int"},{"key":"10.1002\/smrj.54_bb0175","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5539\/gjhs.v6n7p23","article-title":"Evaluation of verapamil efficacy in Peyronie's disease comparing with pentoxifylline","volume":"6","author":"Alizadeh","year":"2014","journal-title":"Glob J Health Sci"},{"key":"10.1002\/smrj.54_bb0180","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2605.2011.01219.x","article-title":"Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: A study of 151 cases","volume":"35","author":"Paulis","year":"2012","journal-title":"Int J Androl"},{"key":"10.1002\/smrj.54_bb0185","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/1871528112666131205112432","article-title":"Long-term multimodal therapy (verapamil associated with propolis, blueberry, vitamin E and local diclofenac) on patients with Peyronie's disease (chronic inflammation of the tunica albuginea). Results of a controlled study","volume":"12","author":"Paulis","year":"2013","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1002\/smrj.54_bb0190","first-page":"294","volume":"1","author":"Maschmann","year":"1937","journal-title":"\u00dcber Bakterienproteasen I. Biochem Z"},{"key":"10.1002\/smrj.54_bb0195","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1042\/bj0420140","article-title":"The biochemistry of the gas gangrene toxins: 5. The kappa-toxin (collagenase) of Clostridium welchii","volume":"42","author":"Bidwell","year":"1948","journal-title":"Biochem J"},{"key":"10.1002\/smrj.54_bb0200","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1172\/JCI102861","article-title":"Isolation and characterization of proteinase and collagenase from Cl. histolyticum","volume":"32","author":"Mandl","year":"1953","journal-title":"J Clin Invest"},{"key":"10.1002\/smrj.54_bb0205","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0003-9861(58)90017-1","article-title":"Clostridium histolyticum collagenase: Its purification and properties","volume":"74","author":"Mandl","year":"1958","journal-title":"Arch Biochem Biophys"},{"key":"10.1002\/smrj.54_bb0210","first-page":"3287","article-title":"Recombinant enzymes for islet isolation: Purification of a collagenase from Clostridium histolyticum and cloning\/expression of the gene","volume":"27","author":"Hesse","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1002\/smrj.54_bb0215","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJM197409122911105","article-title":"Collagenases (first of three parts)","volume":"291","author":"Harris","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1002\/smrj.54_bb0220","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/JB.181.3.923-933.1999","article-title":"Gene duplication and multiplicity of collagenases in Clostridium histolyticum","volume":"181","author":"Matsushita","year":"1999","journal-title":"J Bacteriol"},{"key":"10.1002\/smrj.54_bb0225","doi-asserted-by":"crossref","first-page":"e31430","DOI":"10.1371\/journal.pone.0031430","article-title":"In vitro study of novel collagenase (XIAFLEX\u00ae) on Dupuytren's disease fibroblasts displays unique drug related properties","volume":"7","author":"Syed","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1002\/smrj.54_bb0230","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2337\/diab.38.1.S126","article-title":"Protease activity in pancreatic islet isolation by enzymatic digestion","volume":"38","author":"McShane","year":"1989","journal-title":"Diabetes"},{"key":"10.1002\/smrj.54_bb0235","first-page":"488","article-title":"The effect of bacterial collagenase upon healthy and burned skin of pigs in vitro","volume":"18","author":"Musil","year":"1974","journal-title":"J Hyg Epidemiol Microbiol Immunol"},{"key":"10.1002\/smrj.54_bb0240","first-page":"499","article-title":"Collagenase in the treatment of ulcers in dermatology","volume":"18","author":"Z\u00e1ruba","year":"1974","journal-title":"J Hyg Epidemiol Microbiol Immunol"},{"key":"10.1002\/smrj.54_bb0245","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/jama.1981.03310320052026","article-title":"Injection of collagenase in the treatment of herniated lumbar disk. Initial clinical report","volume":"245","author":"Sussman","year":"1981","journal-title":"JAMA"},{"key":"10.1002\/smrj.54_bb0250","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.bjps.2005.11.022","article-title":"Intra-lesional injections of collagenase are ineffective in the treatment of keloid and hypertrophic scars","volume":"59","author":"Kang","year":"2006","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1002\/smrj.54_bb0255","doi-asserted-by":"crossref","first-page":"497e","DOI":"10.1097\/PRS.0000000000000433","article-title":"Collagenase Clostridium histolyticum injection for plantar fibromatosis (Ledderhose disease)","volume":"134","author":"Hammoudeh","year":"2014","journal-title":"Plast Reconstr Surg"},{"key":"10.1002\/smrj.54_bb0260","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/archopht.1980.01020040681018","article-title":"Bacterial collagenase. Proposed adjunct to vitrectomy with membranectomy","volume":"98","author":"Moorhead","year":"1980","journal-title":"Arch Ophthalmol"},{"key":"10.1002\/smrj.54_bb0265","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0363-5023(96)80102-X","article-title":"The role of transforming growth factor beta in Dupuytren's disease","volume":"21","author":"Badalamente","year":"1996","journal-title":"J Hand Surg [Am]"},{"key":"10.1002\/smrj.54_bb0270","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2106\/00004623-198163050-00014","article-title":"Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease","volume":"63","author":"Brickley-Parsons","year":"1981","journal-title":"J Bone Joint Surg Am"},{"key":"10.1002\/smrj.54_bb0275","doi-asserted-by":"crossref","first-page":"964e","DOI":"10.1097\/01.prs.0000434410.40217.23","article-title":"Dupuytren disease: European hand surgeons, hand therapists, and physical medicine and rehabilitation physicians agree on a multidisciplinary treatment guideline: Results from the HANDGUIDE study","volume":"132","author":"Huisstede","year":"2013","journal-title":"Plast Reconstr Surg"},{"key":"10.1002\/smrj.54_bb0280","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0363-5023(96)80368-6","article-title":"Collagenase in the treatment of Dupuytren's disease: An in vitro study","volume":"21","author":"Starkweather","year":"1996","journal-title":"J Hand Surg [Am]"},{"key":"10.1002\/smrj.54_bb0285","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0266-7681(92)90129-P","article-title":"The long-term results of enzymic fasciotomy","volume":"17","author":"McCarthy","year":"1992","journal-title":"J Hand Surg [Br]"},{"key":"10.1002\/smrj.54_bb0290","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/jhsu.2000.6918","article-title":"Enzyme injection as nonsurgical treatment of Dupuytren's disease","volume":"25","author":"Badalamente","year":"2000","journal-title":"J Hand Surg [Am]"},{"key":"10.1002\/smrj.54_bb0295","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1053\/jhsu.2002.35299","article-title":"Collagen as a clinical target: Nonoperative treatment of Dupuytren's disease","volume":"27","author":"Badalamente","year":"2002","journal-title":"J Hand Surg [Am]"},{"key":"10.1002\/smrj.54_bb0300","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase clostridium histolyticum for Dupuytren's contracture","volume":"361","author":"Hurst","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1002\/smrj.54_bb0305","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11552-014-9645-7","article-title":"Postapproval clinical experience in the treatment of Dupuytren's contracture with collagenase clostridium histolyticum (CCH): The first 1,000 days","volume":"9","author":"Schulze","year":"2014","journal-title":"Hand (N Y)"},{"key":"10.1002\/smrj.54_bb0310","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jhsa.2012.09.028","article-title":"Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data","volume":"38","author":"Peimer","year":"2013","journal-title":"J Hand Surg [Am]"},{"key":"10.1002\/smrj.54_bb0315","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.hcl.2013.08.016","article-title":"Collagenase injections for treatment of Dupuytren disease","volume":"30","author":"Hentz","year":"2014","journal-title":"Hand Clin"},{"key":"10.1002\/smrj.54_bb0320","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0090-4295(80)90028-X","article-title":"Clostridial collagenase and Peyronie disease","volume":"15","author":"Gelbard","year":"1980","journal-title":"Urology"},{"key":"10.1002\/smrj.54_bb0325","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00255956","article-title":"Collagenase for Peyronie's disease experimental studies","volume":"10","author":"Gelbard","year":"1982","journal-title":"Urol Res"},{"key":"10.1002\/smrj.54_bb0330","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0022-5347(17)47123-0","article-title":"The use of collagenase in the treatment of Peyronie's disease","volume":"134","author":"Gelbard","year":"1985","journal-title":"J Urol"},{"key":"10.1002\/smrj.54_bb0335","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0022-5347(17)45768-5","article-title":"Humoral immune responses in Peyronie's disease patients receiving clostridial collagenase therapy","volume":"135","author":"Hamilton","year":"1986","journal-title":"J Urol"},{"key":"10.1002\/smrj.54_bb0340","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-5347(17)35998-0","article-title":"Collagenase vs. placebo in the treatment of Peyronie's disease: A double-blind study","volume":"149","author":"Gelbard","year":"1993","journal-title":"J Urol"},{"key":"10.1002\/smrj.54_bb0345","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.juro.2012.01.032","article-title":"Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease","volume":"187","author":"Gelbard","year":"2012","journal-title":"J Urol"},{"key":"10.1002\/smrj.54_bb0350","author":"Auxilium Pharmaceuticals"},{"key":"10.1002\/smrj.54_bb0355","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.juro.2013.01.090","article-title":"Bother and distress associated with Peyronie's disease: Validation of the Peyronie's disease questionnaire","volume":"190","author":"Hellstrom","year":"2013","journal-title":"J Urol"},{"key":"10.1002\/smrj.54_bb0360","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J Urol"},{"key":"10.1002\/smrj.54_bb0365","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2012.05.040","article-title":"EAU guidelines on penile curvature","volume":"62","author":"Hatzimouratidis","year":"2012","journal-title":"Eur Urol"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052115301402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052115301402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T00:48:51Z","timestamp":1717894131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2050052115301402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S2050052115301402"],"URL":"https:\/\/doi.org\/10.1002\/smrj.54","relation":{},"ISSN":["2050-0521"],"issn-type":[{"value":"2050-0521","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}